期刊文献+

胱抑素C基因真核表达载体的构建及在转染的人主动脉平滑肌细胞中的表达 被引量:1

Construction and Expression of Eukaryotic Expression Vector Containing Gene Cystatin C
下载PDF
导出
摘要 目的克隆人胱抑素C基因及构建胱抑素C基因真核表达载体并研究其在人血管平滑肌细胞中的表达。方法培养人脐静脉内皮细胞系,并从中提取总RNA,采用逆转录聚合酶链反应扩增胱抑素C基因,构建其真核表达载体,双酶切及聚合酶链反应鉴定阳性克隆,转染人血管平滑肌细胞,逆转录聚合酶链反应及Western blot法检测其表达情况。结果成功克隆人胱抑素C基因及构建其真核表达载体,转染后成功高表达。结论克隆人胱抑素C基因及构建其真核表达载体成功,转染人血管平滑肌细胞获得其高表达。 Aim To clone human Cystatin C gene and construct its eukaryotic expression vector to observe the expression in the human vascular smooth muscle cells( VSMC ). Methods Cystatin C gene was obtained from human endothelial cells by reverse transefiption-polymerase chain reaction (RT-PCR) .Molecular cloning technique was used to construct this kind of eukaryotic expression vector, pCDNA3.1-Cystatin C was identified by restriction enzyme and PCR. Using liposome- mediated transfection, the eukaryotic expression vector pCDNA3.1-Cystatin C was transfected into human VSMC and proved by RT-PCR and Western blot. Results The eukaryotic expression vector pCDNA3.1-Cystatin C was constructed correctly and was highly expressed in human VSMC. Conclusion Cystatin C was cloned successfidly, its eukaryotic expression vector was constructed correctly and was expressed highly in human VSMC.
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第2期97-100,共4页 Chinese Journal of Arteriosclerosis
基金 山东省自然科学基金(Y2005C12) 山东省中医管理局资助项目(2005-043)
关键词 病理学与病理生理学 血管平滑肌细胞 胱抑素C基因 克隆 表达载体 Vascular Smooth Muscle Cell Cystatin C Gene Clone Expression Vector
  • 相关文献

参考文献10

  • 1Bokenkamp A,Herget-Rosenthal S,Bokenkamp R.Cystatin C,kidney function and cardiovascluar disease[J].Pediatr Nephrol, 2006, 21 (9) : 1 223-230.
  • 2Sukhova Gig:, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice [ J]. Circ Res, 2005, 96(3): 368-375.
  • 3Wang B, Sun J, Kitamato S, et al. Cathepsin Scontrols angiogenesis and tumor growth via matrix-detived angiogenic factors [ J ]. J Biol Chem, 2006, 281 (9): 6020-029.
  • 4Mangge H, Iebmann P,Tanil H,et al.Csystatin C:an early indicator for incipient renal disease in rbeumatoid artbritis[J].Clin Chim Acta, 2000, 300 (122): 1 951-953.
  • 5Gresser O,Weber E,Hellwig A,et al.Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S[J].Eur J Immunol, 2001, 31 (6) : 1 813-824.
  • 6Cathcart HM,Huang R,Lanham IS,et al.Cystatin C as a risk factor for Alzheimer disease[J].Neurology,2005,64(4):755-757.
  • 7Bengtsson E,To F,Hakansson K,et al.Lack of the cysteine protease inhibitor cystatin C Promotes atherosclerosis in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Bio,2005,25(10):2151-156.
  • 8Jormsjo S, Wuttge DM, Sirsjo A, et al. Differential expression of cysteine and aspartic protceses during progression of atherosclerosis in apolipoprotein E-deficient mice [J]. Am J Pathol, 2002, 161 (3): 939-945.
  • 9Abdul-Hussien H, Soekhoe RG, Weber E, et al. Collagen clan in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases [J]. Am J Pathol, 2007, 170 (3) : 809-817.
  • 10Burns-Kurtis CL, Olziski AB, Needle S, et al. Cathepsin S expression is up- regulated following balloon angioplasty in the hypercholesterolemic rabbit [J]. Res, 2004, 62 (3) : 610-620.

同被引文献14

  • 1韩平治,丁进芳,张翀,司玉春.兰州市健康人血清胱抑素C浓度参考范围的调查[J].国际检验医学杂志,2006,27(2):176-176. 被引量:18
  • 2胡欣,徐岩,史学功,吴继雄,汪太平,于芳,程自平.CystatinC、Hcy及TNF-α在慢性心力衰竭患者血清中的表达变化[J].中国现代医学杂志,2006,16(23):3604-3606. 被引量:9
  • 3董巧玲,刘俊.急性心肌梗死患者血清Cystatin C的变化[J].中国心血管病研究,2007,5(1):27-29. 被引量:19
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 5Koenig W, Twardella D, Brenner H, et al. Plasma con- centration of cystatin C in patients with coronary heart dis- ease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate [ J ]. Clin Chem, 2005, 51 (2): 321-327.
  • 6Noto D, Cefalu AB, Barbagallo CM, et al. Cystatin C lev- els are decreased in acute myocardial infarction. Effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol, 2005, 101 (2) : 213-217.
  • 7Expert Committee on the diagnosis and classification of dia- betes mellitus. Report of the expert committee on diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2003, 26(supl) :S5-S20.
  • 8Anastasi A, Brown MA, Kembhavi AA, et al. Cystatin, a protein inhibitor of cysteine proteinase. Improved purifica- tion from egg white, Characterization, and detection in chicken serum[J]. Bioehem J, 1983, 211 (1) : 129-138.
  • 9Jernberg T, Lindahl B, James S, et al. Cystatin C: a no- vel predictor of outcome in suspected or confirmed non-ST- elevation acute coronary syndrome [ J ]. Circulation, 2004, 110 (16) : 2 342-348.
  • 10Shlipak MG, Katz R, Fried LF, et al. Cystatin C and mortality in elderly persons with heart failure [ J ]. J Am Coll Cardiol, 2005, 45 (2): 268-271.

引证文献1

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部